,,ii #aai? ,,congress #a/ ,session ,s4 #ccjb ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,decemb] #b1 #bjbe,mr4 ,mull9 7= himself1 ,mr4 ,b5net1 ,ms4 ,klobu*>1 ,mrs4 ,%ahe51 ,mr4 ,m>%all1 ,mr4 ,scott ( ,florida1 ,ms4 ,coll9s1 ,mr4 ,coons1 ,mrs4 ,capito1 ,mr4 ,kelly1 ,mr4 ,hu/$1 ,mr4 ,kim1 ,mr4 ,%eehy1 ,mrs4 ,moody1 ,mr4 ,hick5loop]1 ,ms4 ,duckwor?1 ,mr4 ,boozman1 ,mr4 ,s*iff1 ,mr4 ,k5n$y1 ,mr4 ,re$1 ,mr4 ,s*mitt1 ,mr4 ,m>key1 ,mr4 ,book]1 & ,mr4 ,ju/ice7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ,a ,,bill ,to am5d ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act ) respect to molecul>ly t>get$ p$iatric canc] inve/igations1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,mikaela ,naylon ,give ,kids a ,*ance ,act ( #bjbe4 #b4 ,rese>* into p$iatric uses ( drugs2 additional au?orities ( ,food & ,drug ,adm9i/ration reg>d+ molecul>ly t>get$ canc] drugs 7a7 ,9 g5]al 7#a7 ,additional active +r$i5t = application drug2 limitation reg>d+ novel-comb9ation application drug ,section #eje;,b7a77#c7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;c7a77#c77 is am5d$-- 7,a7 by r$esignat+ subp>agraphs 7,b7 & 7,c7 z subp>agraphs 7,c7 & 7,d71 respectively2 & 7,b7 by /rik+ subp>agraph 7,a7 & ins]t+ ! foll[+3 7,a7 ,9 g5]al ,= purposes ( p>agraph 7#a77;,b71 ! inve/igation describ$ 9 ?is p>agraph is a molecul>ly t>get$ p$iatric canc] inve/igation (-- 7i7 ! drug or biological product = :i* ! application ref]r$ to 9 su* p>agraph is submitt$2 or 7ii7 su* drug or biological product us$ 9 comb9ation )-- 7,i7 an active +r$i5t ( a drug or biological product-- 7aa7 = :i* an approv$ application "u section #eje7;j7 "u ?is ,act or "u section #cea7k7 ( ! ,public ,heal? ,s]vice ,act is 9 effect2 & 7bb7 t is det]m9$ by ! ,secret>y1 aft] consultation ) ! applicant1 to be "p ( ! /&>d ( c>e = treat+ a p$iatric canc]2 or 7,,ii7 an active +r$i5t ( a drug or biological product-- 7aa7 = :i* an approv$ application "u section #eje7;b7 ( ?is ,act or section #cea7;a7 ( ! ,public ,heal? ,s]vice ,act to treat an adult canc] is 9 effect & is held by ! same p]son submitt+ ! application "u p>agraph 7#a77;,b72 & 7bb7 t is direct$ at a molecul> t>get t ! ,secret>y det]m9es to be sub/antially relevant to ! gr[? or progression ( a p$iatric canc]4 7,b7 ,additional requirem5ts 7i7 ,design ( inve/igation ,a molecul>ly t>get$ p$iatric canc] inve/igation ref]r$ to 9 subp>agraph 7,a7 %all be design$ to yield cl9ically mean+ful p$iatric /udy data t is ga!r$ us+ appropriate =mulations = ea* age gr\p = :i* ! /udy is requir$1 reg>d+ dos+1 safety1 & prelim9>y efficacy to in=m pot5tial p$iatric label+4 7ii7 ,limitation ,an inve/igation describ$ 9 subp>agraph 7,a77ii7 may be requir$ only if ! drug or biological product = :i* ! application ref]r$ to 9 p>agraph 7#a77;,b7 conta9s ei!r-- 7,i7 a s+le new active +r$i5t2 or 7,,ii7 m ?an "o active +r$i5t1 if an application = ! comb9ation ( active +r$i5ts has n previ\sly be5 approv$ b ea* active +r$i5t is 9 a drug product t has be5 previ\sly approv$ to treat an adult canc]4 7iii7 ,results ( already-complet$ precl9ical /udies ( application drug ,) respect to an inve/igation requir$ pursuant to p>agraph 7#a77;,b71 ! ,secret>y may require ! results ( any complet$ precl9ical /udies relevant to ! initial p$iatric /udy plan be submitt$ to ! ,secret>y at ! same "t t ! initial p$iatric /udy plan requir$ "u subsection 7e77#a7 is submitt$4 7iv7 ,rule ( con/ruction reg>d+ inactive +r$i5ts ,) respect to a comb9ation ( active +r$i5ts ref]r$ to 9 subp>agraph 7,a77ii71 su* subp>agraph %all n be con/ru$ z address+ ! use ( inactive +r$i5ts ) su* comb9ation4 4 7#b7 ,det]m9ation ( applicable requirem5ts ,section #eje;,b7e77#a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;c7e77#a77 is am5d$ by add+ at ! end ! foll[+3 ,! ,secret>y %all det]m9e :e!r subp>agraph 7,a7 or 7,b7 ( subsection 7a77#a7 applies ) respect to an application be=e ! date on :i* ! applicant is requir$ to submit ! initial p$iatric /udy plan "u p>agraph 7#b77;,a744 7#c7 ,cl>ify+ applicability ,section #eje;,b7a77#a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;c7a77#a77 is am5d$ by add+ at ! end ! foll[+3 7,c7 ,rule ( con/ruction ,no application t is subject to ! requirem5ts ( subp>agraph 7,b7 %all be subject to ! requirem5ts ( subp>agraph 7,a71 & no application 7or supplem5t to an application7 t is subject to ! requirem5ts ( subp>agraph 7,a7 %all be subject to ! requirem5ts ( subp>agraph 7,b74 4 7#d7 ,con=m+ am5dm5ts ,section #eje;,b7a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;c7a77 is am5d$-- 7,a7 9 p>agraph 7#c77;,c71 z r$esignat$ by p>agraph 7#a77;,a7 ( ?is subsection1 by /rik+ inve/igations describ$ 9 ?is p>agraph & ins]t+ inve/igations ref]r$ to 9 subp>agraph 7,a72 & 7,b7 9 p>agraph 7#c77;,d71 z r$esignat$ by p>agraph 7#a77;,a7 ( ?is subsection1 by /rik+ ! assessm5ts "u p>agraph 7#b77;,b7 & ins]t+ ! assessm5ts requir$ "u p>agraph 7#a77;,a74 7b7 ,guidance ,! ,secret>y ( ,heal? & ,human ,s]vices1 act+ ?r\gh ! ,commission] ( ,food & ,drugs1 %all-- 7#a7 n lat] ?an #ab mon?s aft] ! date ( enactm5t ( ?is ,act1 issue draft guidance on ! implem5tation ( ! am5dm5ts made by subsection 7a72 & 7#b7 n lat] ?an #ab mon?s aft] clos+ ! comm5t p]iod on su* draft guidance1 f9alize su* guidance4 7c7 ,applicability ,! am5dm5ts made by ?is section apply ) respect to any application "u section #eje7;b7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;b77 & any application "u section #cea7;a7 ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bfb7;a771 t is submitt$ on or aft] ! date t is #c ye>s aft] ! date ( enactm5t ( ?is ,act4 7d7 ,reports to ,congress 7#a7 ,secret>y ( ,heal? & ,human ,s]vices ,n lat] ?an #f ye>s aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices %all submit to ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives & ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate a report on ! ,secret>y's ef=ts1 9 coord9ation ) indu/ry1 to ensure implem5tation ( ! am5dm5ts made by subsection 7a74 7#b7 ,,gao /udy & report 7,a7 ,/udy ,n lat] ?an #h ye>s aft] ! date ( enactm5t ( ?is ,act1 ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all conduct a /udy ( ! effectiv5ess ( requir+ assessm5ts & inve/igations describ$ 9 section #eje;,b ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee;c71 z am5d$ by subsection 7a71 9 ! developm5t ( drugs & biological products = p$iatric canc] indications1 includ+ consid]ation ( any b5efits to1 or burd5s on1 p$iatric canc] drug developm5t4 7,b7 ,f9d+s ,n lat] ?an #aj ye>s aft] ! date ( enactm5t ( ?is ,act1 ! ,comptroll] ,g5]al %all submit to ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives & ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate a report conta9+ ! f9d+s ( ! /udy conduct$ "u subp>agraph 7,a74 #c4 ,ext5sion ( au?ority to issue priority review v\*]s to enc\rage treatm5ts = r>e p$iatric diseases 7a7 ,ext5sion ,section #ebi7;b77#e7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff7b77#e77 is am5d$ by /rik+ ,decemb] #bj1 #bjbd1 unless & all t foll[s ?r\gh ! p]iod at ! end & ins]t+ ,septemb] #cj1 #bjcj44 7b7 ,us] fee paym5t ,subsection #ebi7;c77#d7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff7c77#d77 is am5d$ by /rik+ subp>agraph 7,a7 & ins]t+ ! foll[+3 7,a7 ,9 g5]al ,! priority review us] fee requir$ by ?is subsection %all be due ^u ! submission ( a human drug application "u section #eje7;b77#a7 or section #cea7;a7 ( ! ,public ,heal? ,s]vice ,act = :i* ! priority review v\*] is us$4 ,all o!r us] fees associat$ ) ! human drug application %all be due z requir$ by ! ,secret>y or "u applicable law4 4 7c7 ,,gao report on effectiv5ess ( r>e p$iatric disease priority v\*] aw>ds 9 inc5tiviz+ r>e p$iatric disease drug developm5t 7#a7 ,,gao /udy 7,a7 ,/udy ,! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all conduct a /udy ( ! effectiv5ess ( aw>d+ r>e p$iatric disease priority v\*]s "u section #ebi ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff71 z am5d$ by subsection 7a71 9 ! developm5t ( human drug products t treat or prev5t r>e p$iatric diseases 7z def9$ 9 su* section #ebi74 7,b7 ,cont5ts ( /udy ,9 conduct+ ! /udy "u subp>agraph 7,a71 ! ,comptroll] ,g5]al %all exam9e ! foll[+3 7i7 ,! indications = ea* drug or biological product t-- 7,i7 is ! subject ( a r>e p$iatric disease product application 7z def9$ 9 section #ebi ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff77 = :i* a priority review v\*] 0 aw>d$2 & 7,,ii7 0 approv$ "u section #eje ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#db ,u4,s4,c4 #cee7 or lic5s$ "u section #cea ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bfb74 7ii7 ,:e!r1 & to :at ext5t1 an unmet ne$ relat$ to ! treatm5t or prev5tion ( a r>e p$iatric disease 0 met ?r\gh ! approval or lic5sure ( su* a drug or biological product4 7iii7 ,! size ( ! company to :i* a priority review v\*] 0 aw>d$ "u section #ebi ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff7 = su* a drug or biological product4 7iv7 ,! value ( su* priority review v\*] if transf]r$4 7v7 ,id5tification ( ea* drug = :i* a priority review v\*] aw>d$ "u su* section #ebi 0 us$4 7vi7 ,! size ( ! company us+ ea* priority review v\*] aw>d$ "u su* section #ebi4 7vii7 ,! l5g? ( ! p]iod ( "t betwe5 ! date on :i* a priority review v\*] 0 aw>d$ "u su* section #ebi & ! date on :i* x 0 us$4 7viii7 ,:e!r1 & to :at ext5t1 an unmet ne$ relat$ to ! treatm5t or prev5tion ( a r>e p$iatric disease 0 met ?r\gh ! approval "u section #eje ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#db ,u4,s4,c4 #cee7 or lic5sure "u section #cea ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bfb7 ( a drug = :i* a priority review v\*] 0 us$4 7ix7 ,:e!r1 & to :at ext5t1 companies 7 motivat$ by ! availability ( priority review v\*]s "u section #ebi ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;ff7 to attempt to develop a drug = a r>e p$iatric disease4 7x7 ,:e!r1 & to :at ext5t1 p$iatric review v\*]s aw>d$ "u su* section 7 successful 9 /imulat+ developm5t & exp$it$ pati5t access to drug products = treatm5t or prev5tion ( a r>e p$iatric disease t w\ldn't o!rwise take place )\t ! inc5tive provid$ by su* v\*]s4 7xi7 ,! impact ( su* priority review v\*]s on ! workload1 review process1 & public heal? prioritization ef=ts ( ! ,food & ,drug ,adm9i/ration4 7xii7 ,any o!r inc5tives 9 ,f$]al law t exi/ = companies develop+ drugs or biological products describ$ 9 clause 7i74 7#b7 ,report on f9d+s ,n lat] ?an #e ye>s aft] ! date ( ! enactm5t ( ?is ,act1 ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all submit to ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives & ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate a report conta9+ ! f9d+s ( ! /udy conduct$ "u p>agraph 7#a74